Clinical Trial Update: Nabilone for Agitation in Frontotemporal Dementia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nabilone for agitation in frontotemporal dementia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behavioral Variant Frontotemporal Dementia
• Frontotemporal Dementia
• Progressive Aphasia

Drugs mentioned

• Nabilone (nabilone)

Snippet

Sponsor: Simon Ducharme, MD | Conditions: Frontotemporal Dementia, Frontotemporal Dementia, Behavioral Variant | Phase 2 | Status: RECRUITING